ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Hawaii » Internal Medicine

Top Internal Medicine Prescribers in Hawaii

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KEITH WOO M.D.

Internal Medicine

41,851

$3.27M

908
860 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 27%

$78
Average prescription price

Avg: $69

RODNEY ONO M.D.

Internal Medicine

26,941

$1.45M

831
763 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $69

JACK ZHOU MD

Internal Medicine

24,964

$1.53M

859
765 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $69

CHANG LAI MD

Internal Medicine

23,139

$1.65M

751
648 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $69

CONSTANTE FLORA M.D.

Internal Medicine

18,227

$987K

747
656 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $69

JOSE DELEON M.D.

Internal Medicine

17,710

$1.13M

471
385 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $69

CARLOS LAM M.D.

Internal Medicine

16,599

$863K

557
398 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 6%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $69

CRAIG SHIKUMA M.D.

Internal Medicine

15,825

$1.12M

510
463 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $69

MICHAEL BRAUN M.D.

Internal Medicine

13,950

$962K

542
522 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $69

THOMAS TAN MD

Internal Medicine

13,856

$1.02M

483
417 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 27%

$74
Average prescription price

Avg: $69

GLENN UTO MD

Internal Medicine

13,454

$1.52M

516
491 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $69

MARIA ILAR-REVILLA M.D.

Internal Medicine

13,435

$533K

545
488 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 6%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 27%

$40
Average prescription price

Avg: $69

SYDNEY TATSUNO MD

Internal Medicine

13,106

$841K

592
543 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $69

STEPHEN ARNOLD M.D.

Internal Medicine

13,003

$978K

747
708 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $69

PETER WAI MD

Internal Medicine

12,784

$934K

553
521 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $69

STEVEN LUM MD

Internal Medicine

12,296

$988K

550
511 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$80
Average prescription price

Avg: $69

CLARA YONG M.D.

Internal Medicine

12,227

$781K

460
419 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $69

CRAIG KADOOKA M.D.

Internal Medicine

12,081

$632K

380
360 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 6%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $69

LILIANE KHENG M.D.

Internal Medicine

11,910

$833K

509
454 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $69

DANIEL GARCIA M.D.

Internal Medicine

11,467

$742K

468
376 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $69

ALAN DESILVA

Internal Medicine

11,423

$587K

469
442 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $69

FRED TANABE M.D.

Internal Medicine

11,330

$898K

511
481 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $69

DANIEL BELCHER M.D.

Internal Medicine

11,110

$731K

485
395 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $69

AARON MORITA M.D., F.A.C.P.

Internal Medicine

10,928

$619K

398
369 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $69

SCOTT HIMEDA MD

Internal Medicine

10,801

$835K

664
632 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$77
Average prescription price

Avg: $69

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank